Skip to content
OpenCapital
Get started

Korro Bio, Inc. KRRO Q4 2024 Annual earnings

Reported March 18, 2025 · Before market open

Revenue$2.3M
EPS-$2.26Beat by $0.07
EPS estimate-$2.33

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$214.3K
EPS estimate-$1.34

Versus estimates

Revenue

Q4 2025$1.3MBeat by $600.0KQ3 2025$1.1MBeat by $665.0KQ2 2025$1.5MBeat by $1.1MQ1 2025$2.6MBeat by $2.1M
Q4 2024$2.3M

Diluted EPS

Q1 2026-$1.69Miss by $0.09Q4 2025-$5.32Miss by $3.39Q3 2025-$1.92Beat by $0.69Q2 2025-$2.74Miss by $0.20Q1 2025-$2.49Beat by $0.11
Q4 2024-$2.26Beat by $0.07

Ask the moment Korro Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Korro Bio, Inc. report Q4 2024 earnings?
Korro Bio, Inc. (KRRO) reported Q4 2024 earnings on March 18, 2025 before market open.
What were Korro Bio, Inc.'s Q4 2024 revenue and EPS?
Korro Bio, Inc. reported revenue of $2.3M and eps of $-2.26 for Q4 2024.
Did Korro Bio, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-2.33 by $0.07.
Where can I find Korro Bio, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-040759) directly on SEC EDGAR. The filing index links above go to sec.gov.